Drugs / Anti-Adhesion Product
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00512356 | Dec 2000 → Feb 2003 | — | Baxter Healthcare Corporation | Completed | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Anti-Adhesion Product | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00512356 ↗ |
| Known as | AAP | “Anti-Adhesion Product (AAP) is a biological two-component product of human origin.” NCT00512356 ↗ |
| Modality | Protein / enzyme biologic | “Anti-Adhesion Product (AAP) is a biological two-component product of human origin.” NCT00512356 ↗ |
| Route | Other | “AAP was applied to the rectal stump and the incision line” NCT00512356 ↗ |